Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

399.47
+26.287.04%
Post-market: 405.045.57+1.39%16:23 EDT
Volume:998.97K
Turnover:395.16M
Market Cap:19.90B
PE:46.40
High:403.01
Open:382.42
Low:371.54
Close:373.19
52wk High:412.31
52wk Low:138.61
Shares:49.82M
Float Shares:48.50M
Volume Ratio:1.49
T/O Rate:2.06%
Dividend:0.80
Dividend Rate:0.20%
EPS(TTM):8.61
EPS(LYR):7.42
ROE:23.49%
ROA:10.75%
PB:10.02
PE(LYR):53.84

Loading ...

BRIEF-Carpenter Technology Q2 Adjusted EPS USD 2.33 Vs. IBES Estimate USD 2.24

Reuters
·
Jan 29

Carpenter Technology Corp: Adjusted Free Cash Flow Outlook Raised to Be at Least $280 Mln in Fiscal Year 2026

THOMSON REUTERS
·
Jan 29

Carpenter Technology Q2 EPS USD 2.09

THOMSON REUTERS
·
Jan 29

Carpenter Technology Q2 Sales USD 728 Million VS. Ibes Estimate USD 735.2 Million

THOMSON REUTERS
·
Jan 29

Carpenter Technology Corp: Q3 Fiscal 2026 Operating Income Anticipated Between $177 Mln to $182 Mln

THOMSON REUTERS
·
Jan 29

Carpenter Technology Reports Second Quarter Fiscal Year 2026 Results

GlobeNewswire
·
Jan 29

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jan 29

Nyse Order Imbalance 89259.0 Shares on Sell Side

THOMSON REUTERS
·
Jan 28

Carpenter Technology (CRS) Gets a Buy from J.P. Morgan

TIPRANKS
·
Jan 27

Earning Preview: Carpenter Technology revenue is expected to increase by 1.98% this quarter, and institutional views are bullish.

Earnings Agent
·
Jan 22

Is Dividend Hike, Investment-Grade Rating and New Debt Deal Altering The Investment Case For Carpenter Technology (CRS)?

Simply Wall St.
·
Jan 19

Carpenter Technology Partners Keeps Quarterly Dividend at $0.20 a Share, Payable Mar. 5 to Holders of Record Jan. 27

MT Newswires Live
·
Jan 17

Press Release: Carpenter Technology Declares Quarterly Cash Dividend

Dow Jones
·
Jan 17

Analysts Offer Insights on Industrial Goods Companies: Carpenter Technology (CRS) and RELX plc (OtherRLXXF)

TIPRANKS
·
Jan 17

Think Overseas Income Escapes Tax Authorities? Time to Debunk This "Look-Back Period" Myth

Deep News
·
Jan 16

Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs

prnewswire
·
Jan 16

Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook

GlobeNewswire
·
Jan 09

SeaStar Medical Announces 2026 Milestones

GlobeNewswire
·
Jan 07

We Think Caprice Resources (ASX:CRS) Can Afford To Drive Business Growth

Simply Wall St.
·
Jan 07

Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell Shuttle™ Platform

GlobeNewswire
·
Jan 06